Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Published:2024-07 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Leroux-Roels Isabel,Prajeeth Chittappen Kandiyil,Aregay Amare,Nair Niranjana,Rimmelzwaan Guus F,Osterhaus Albert D M E,Kardinahl Simone,Pelz Sabrina,Bauer Stephan,D'Onofrio Valentino,Alhatemi Azhar,Jacobs Bart,De Boever Fien,Porrez Sharon,Waerlop Gwenn,Punt Carine,Hendriks Bart,von Mauw Ellemieke,van de Water Sandra,Harders-Westerveen Jose,Rockx Barry,van Keulen Lucien,Kortekaas Jeroen,Leroux-Roels Geert,Wichgers Schreur Paul J

Funder

Coalition for Epidemic Preparedness Innovations

Horizon 2020 Framework Programme

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Reference30 articles.

1. Rift Valley fever: biology and epidemiology;Wright;J Gen Virol,2019

2. Ocular manifestations of emerging viral diseases;Venkatesh;Eye (Lond),2021

3. Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study;Baudin;Lancet Glob Health,2016

4. Potential vectors of Rift Valley fever virus in the Mediterranean region;Moutailler;Vector Borne Zoonotic Dis,2008

5. Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus;Turell;J Med Entomol,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A promising boost for the Rift Valley fever vaccine pipeline;The Lancet Infectious Diseases;2024-07